PNTG — The Pennant Group, Inc.

Summary of The Pennant Group (PNTG) Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 2025 Adjusted EPS: $0.34
• Full Year 2025 Adjusted EPS: $1.18, exceeding guidance of $1.16.
• Total Revenue (2025): $947.7 million, up 36.3% year-over-year.
• Adjusted EBITDA (2025): $72.5 million, a 36% increase.
• Adjusted EBITDA prior to NCI: $76.7 million, a 39.2% increase.
• Net Debt to Adjusted EBITDA Ratio: 1.7x, well below the covenant limit of 3.25x.
• Cash Flow from Operations (Q4): $21 million; year-to-date total of $48.3 million.

2. Strategic Updates and Business Highlights:

• Acquisitions:
  • Acquired Signature Healthcare at Home in January 2025 and over 50 locations from UnitedHealth and Amedisys in October 2025.
  • Continued focus on integrating these acquisitions while optimizing existing operations.
• Leadership Development: Added over 100 leaders to the CEO training program and elevated 39 leaders to C-level positions.
• Operational Excellence: Focus on improving same-store operations and driving clinical outcomes, with a notable rise in average CMS star ratings to 4.2.
• Senior Living Segment: Revenue improved to $215 million, a 22.3% increase over the prior year, with occupancy and adjusted EBITDA also showing strong growth.

3. Forward Guidance and Outlook:

• 2026 Revenue Guidance: $1.13 billion to $1.17 billion (22.4% increase at midpoint).
• Adjusted EBITDA Guidance: $88.5 million to $94.1 million (26% increase at midpoint).
• Adjusted EPS Guidance: $1.26 to $1.36, with a midpoint of $1.31.
• Anticipates a ramp-up in performance throughout the year, particularly in the first half as new acquisitions are integrated.

4. Bad News, Challenges, or Points of Concern:

• Integration Challenges: The integration of the Amedisys and UnitedHealth assets may cause initial operational noise and performance variability.
• Reimbursement Environment: Ongoing headwinds in the reimbursement landscape, particularly for home health services, could impact revenue growth.
• Market Competition: Increased competition from larger, payer-owned competitors may pressure market share and pricing strategies.

5. Notable Q&A Insights:

• Guidance Conservatism: CFO Lynette Walbom acknowledged a conservative approach to guidance due to expected integration noise and transitional challenges.
• Joint Ventures: John Gochnour discussed the strategic value of joint ventures, emphasizing strong local leadership and collaboration with health systems to enhance clinical outcomes.
• Market Share Opportunities: The company sees potential for market share gains in the Southeast, particularly as it integrates new operations and leverages its local leadership model.
• Senior Living Margins: Discussion on the potential for improved margins in senior living through increased occupancy and revenue per occupied room, with expectations for continued operational improvements.

Overall, Pennant Group reported strong financial performance in 2025, driven by strategic acquisitions and operational excellence, while acknowledging challenges related to integration and competitive pressures in the healthcare landscape.